Advising a global medical device company in its multinational patent defense strategy against a German competitor.
Agathe Michel-de Cazotte
Agathe Michel-de Cazotte focuses her practice on patent law. As a qualified engineer in the fields of microelectronics and optics, her technical background helps her solve complex legal issues whilst taking into account the requirements of the specific technology involved.
She is currently part-time seconded to our London office; hence acts in matters on a purely German and also on an international level. She focuses on litigation and counselling related to infringement and validity issues as well as on patent portfolio assessment and technology transfer aspects, with a focus on the pharma and telecom areas.
Before joining our German team, Agathe spent some time in the legal department of IBM in France and a year as a researcher in the Thales labs in Singapore. She therefore has an understanding of the business and R&D needs of large innovative companies and brings this knowledge into play when creative legal problem solving for her clients is required.
Agathe studied in Paris and Singapore and holds master degrees in physics, optics, micro-electronics and law. While she was a student at Sciences Po Paris, she was treasurer of the intellectual property society and organized several IP events. She is admitted to the bar in Paris and counts among the laureates of her year.
Assisting a leading Asian handset manufacturer in the defence against a patent troll asserting its SEPs in the field of voice coding.
Advising a leading pharmaceutical company on Bolar exemption in Germany.
Assisting a leading pharmaceutical company in its patent defense strategy in the stent field.
Advising a leading Asian actor in the integrated circuits industry in its patent portfolio management.
Assisting leading American handset manufacturer in defending against a patent troll in the field of semicon wafers.
Advising a leading Norwegian actor in the gas and oil industry in patent portfolio assessment for an acquisition.
Advising an innovative American actor in the nuclear energy field in patent portfolio assessment for a merger.
Advising a leading American pharma company in injunction proceedings against generic manufacturers.